For the Inventor, By the Inventor

Enter assignee name

Brussels, Belgium

Université Libre De Bruxelles

Calculating rank

USPTO Granted Patents = 99

% Expired Patents = 41.4

CIPO Patents = 16

EPO Patents = 70

Forward Citations = 478

Loading Chart...

Loading Chart...

272 inventors (with patents filed for the assignee):

Jacques Deviere (10 out of 11 patents)

Nicolas Cauche (9 out of 12 patents)

Philippe Gabant (9 out of 17 patents)

4. Frank Dubois (7 out of 7 patents)

5. Michel Goldman (6 out of 8 patents)

6. Alain Delchambre (5 out of 5 patents)

7. Laurence Van Melderen (5 out of 5 patents)

8. Catherine Yourassowsky (5 out of 5 patents)

9. Robert Kiss (5 out of 7 patents)

10. Patrick Stordeur (5 out of 5 patents)

11. Cédric Szpirer (4 out of 7 patents)

12. Sonia Dugardeyn (4 out of 4 patents)

13. Martyn G Folan (3 out of 86 patents)

14. Thomas M Keating (3 out of 30 patents)

15. François Huberland (3 out of 3 patents)

Core Competencies:

Stents

Cancer Treatments

Gene Expression

Diabetes Diagnosis

Optical Methods

Neuronal Cells

Biomarkers

Quantum Key Distribution

Bioinformatics

Drug Delivery

Anti-Cancer Agents

Inhalation Formulations

99 patents: Sort by Forward Citations

1. 12721871 - PROBIOTICS FOR THE PREVENTION OR TREATMENT OF VIRAL RESPIRATORY INFECTIONS (2026-09-01),

2. 12656406 - State-of-health estimation pipeline for Li-ion battery packs with heterogeneous cells (2026-06-16),

3. 12628822 - PLANT PATHOGEN DEFENCE ELICITORS (2026-05-19),

4. 12575923 - Stents, systems, and methods for gastrointestinal tract treatment (2026-03-17),

5. 12492230 - ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES (2025-12-09),

6. 12460153 - Method for transforming an essential oil (2025-11-04),

7. 12455493 - Active optical resonator for frequency conversion (2025-10-28),

8. 12422729 - Quasi-deterministic single-photon source (2025-09-23),

9. 12239708 - Dry powder inhalation formulation and its use for the therapeutic treatment of lungs (2025-03-04),

10. 12239524 - Esophageal stent including an inner liner (2025-03-04),

11. 12220144 - Method for shearing tissue (2025-02-11),

12. 12203078 - Inducible promoter for gene expression and synthetic biology (2025-01-21),

13. 12197513 - Method for extracting data associated with a view of an application, a related analysis device and a related mobile computing device (2025-01-14),

14. 12133986 - Tissue anchoring assembly (2024-11-05),

15. 12123877 - Detection, quantification and/or isolation of circulating tumor cells based on the expression of CD321 marker (2024-10-22),

Company Overview

Université Libre De Bruxelles is a prominent research institution located in Brussels, Belgium, specializing in biomedical engineering. The university is engaged in cutting-edge research across various domains, including the development of stents, innovative cancer treatments, and advanced methods for gene expression analysis. Its work extends to diabetes diagnosis, optical methods, and the study of neuronal cells, as well as the exploration of biomarkers and quantum key distribution technologies. The institution fosters a collaborative environment that encourages interdisciplinary research and innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

99 Patents

#17 in Brussels

#51 in Belgium

#7,857 in the World

Brussels, Belgium

Université Libre De Bruxelles

Forward Citations = 478

272 inventors:

Jacques Deviere (10 out of 11 patents)

Nicolas Cauche (9 out of 12 patents)

Philippe Gabant (9 out of 17 patents)

4. Frank Dubois (7 out of 7 patents)

5. Michel Goldman (6 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Université Libre De Bruxelles. Retrieved from https://idiyas.com/company/universite-libre-de-bruxelles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…